HC
SANA icon

Hurley Capital’s Sana Biotechnology SANA Stock Holding History

Hurley Capital’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.76K Hold
2,000
– – ﹤0.01% 402
2025
Q4 		$8.14K Hold
2,000
– – ﹤0.01% 355
2025
Q3 		$7.1K Buy
+2,000
New +$7.23K ﹤0.01% 403

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Hurley Capital's SANA Position: Q1 2026 in Review

Hurley Capital held its Sana Biotechnology (SANA) position steady in Q1 2026 at 2,000 shares worth $5.76K. The position accounts for ﹤0.01% of the portfolio, ranked #402.

Hurley Capital first reported a position in SANA in Q3 2025 and has held it in 3 quarters since. The position peaked at $8.14K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Hurley Capital held 2,000 shares of Sana Biotechnology worth $5.76K as of Q1 2026.
  • Hurley Capital left its Sana Biotechnology share count unchanged in Q1 2026.
  • Sana Biotechnology made up ﹤0.01% of Hurley Capital's portfolio in Q1 2026, its #402 holding.
  • Hurley Capital first reported a position in Sana Biotechnology in Q3 2025 and has held it in 3 quarters since.
  • Hurley Capital's Sana Biotechnology position peaked at $8.14K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.